z-logo
open-access-imgOpen Access
Favipiravir: a promising investigational agent in preventing infection and progression of COVID-19
Author(s) -
Sidharth Mehta,
Himanshi Tanwar,
Pooja Ran
Publication year - 2022
Publication title -
clinical research communications
Language(s) - English
Resource type - Journals
ISSN - 2815-7176
DOI - 10.53388/crc20220005
Subject(s) - favipiravir , covid-19 , investigational drugs , medicine , virology , rescue therapy , intensive care medicine , clinical trial , infectious disease (medical specialty) , outbreak , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom